Stocks and InvestingStocks and Investing
Mon, May 18, 2020
Fri, May 15, 2020
Thu, May 14, 2020
Wed, May 13, 2020

Andrew Fein Reiterated (STRO) at Strong Buy with Decreased Target to $17 on, May 13th, 2020


Published on 2024-10-27 06:21:31 - WOPRAI, Andrew Fein
  Print publication without navigation


Andrew Fein of HC Wainwright & Co., Reiterated "Sutro Biopharma, Inc." (STRO) at Strong Buy with Decreased Target from $18 to $17 on, May 13th, 2020.

Andrew has made no other calls on STRO in the last 4 months.



There is 1 other peer that has a rating on STRO. Out of the 1 peers that are also analyzing STRO, 0 agree with Andrew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Andrew


  • Asthika Goonewardene of "SunTrust Robinson Humphrey" Initiated at Strong Buy and Held Target at $18 on, Monday, January 13th, 2020